These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9760694)

  • 21. Differences in partial agonist action at cholecystokinin receptors of mouse and rat are dependent on parameters extrinsic to receptor structure: molecular cloning, expression and functional characterization of the mouse type A cholecystokinin receptor.
    Ghanekar D; Hadac EM; Holicky EL; Miller LJ
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1206-12. PubMed ID: 9316827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists.
    Sherrill RG; Berman JM; Birkemo L; Croom DK; Dezube M; Ervin GN; Grizzle MK; James MK; Johnson MF; Queen KL; Rimele TJ; Vanmiddlesworth F; Sugg EE
    Bioorg Med Chem Lett; 2001 May; 11(9):1145-8. PubMed ID: 11354363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric emptying in OLETF rats not expressing CCK-A receptor gene.
    Shoji E; Okumura T; Onodera S; Takahashi N; Harada K; Kohgo Y
    Dig Dis Sci; 1997 May; 42(5):915-9. PubMed ID: 9149042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.
    Tanaka T; Mizumoto A; Muramatsu S; Mochiki E; Haga N; Suzuki H; Itoh Z
    Dig Dis Sci; 1999 Aug; 44(8):1516-24. PubMed ID: 10492127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capsaicin-sensitive vagal fibres and 5-HT3-, gastrin releasing peptide- and cholecystokinin A-receptors are involved in distension-induced inhibition of gastric emptying in the rat.
    Bozkurt A; Oktar BK; Kurtel H; Alican I; Coşkun T; Yeğen BC
    Regul Pept; 1999 Sep; 83(2-3):81-6. PubMed ID: 10511461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCK peptides with combined features of hexa- and tetrapeptide CCK-A agonists.
    Pierson ME; Comstock JM; Simmons RD; Julien R; Kaiser F; Rosamond JD
    J Med Chem; 2000 Jun; 43(12):2350-5. PubMed ID: 10882360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity.
    Berger R; Zhu C; Hansen AR; Harper B; Chen Z; Holt TG; Hubert J; Lee SJ; Pan J; Qian S; Reitman ML; Strack AM; Weingarth DT; Wolff M; Macneil DJ; Weber AE; Edmondson SD
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4833-7. PubMed ID: 18684621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of evodiamine on gastrointestinal motility in male rats.
    Wu CL; Hung CR; Chang FY; Lin LC; Pau KY; Wang PS
    Eur J Pharmacol; 2002 Dec; 457(2-3):169-76. PubMed ID: 12464363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419.
    Tabuchi S; Ito H; Sogabe H; Kuno M; Kinoshita T; Katumi I; Yamamoto N; Mitsui H; Satoh Y
    Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):1-15. PubMed ID: 10705468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of cholecystokinin in appetite control and body weight regulation.
    Little TJ; Horowitz M; Feinle-Bisset C
    Obes Rev; 2005 Nov; 6(4):297-306. PubMed ID: 16246215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a series of CCK-2 receptor nonpeptide agonists: sensitivity to stereochemistry and a receptor point mutation.
    Kopin AS; McBride EW; Chen C; Freidinger RM; Chen D; Zhao CM; Beinborn M
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5525-30. PubMed ID: 12697901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.
    Konturek JW; Thor P; Maczka M; Stoll R; Domschke W; Konturek SJ
    Scand J Gastroenterol; 1994 Jul; 29(7):583-90. PubMed ID: 7939393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
    Chang RS; Lotti VJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4923-6. PubMed ID: 3014520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
    Varga G; Scarpignato C
    Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites.
    Moran TH; Kornbluh R; Moore K; Schwartz GJ
    Regul Pept; 1994 Aug; 52(3):165-72. PubMed ID: 7800848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells.
    Dunlop J; Zhang Y; Evans N
    Peptides; 1997; 18(6):865-8. PubMed ID: 9285936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermolecular interactions between peptidic and nonpeptidic agonists and the third extracellular loop of the cholecystokinin 1 receptor.
    Giragossian C; Sugg EE; Szewczyk JR; Mierke DF
    J Med Chem; 2003 Jul; 46(16):3476-82. PubMed ID: 12877585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel CCK-B receptor agonists: diketopiperazine analogues derived for CCK4 bioactive conformation.
    Weng JH; Bado A; Garbay C; Roques BP
    Regul Pept; 1996 Aug; 65(1):3-9. PubMed ID: 8876029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are radioligand antagonist/agonist binding ratios in rat pancreas predictive of functional efficacy of cholecystokinin receptor agonists and antagonists?
    Patel S; Chapman KL; Smith AJ; Bailey I; Freedman SB
    Regul Pept; 1996 Aug; 65(1):29-35. PubMed ID: 8876033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.